Materialise NV (EBR:MTLS)
Belgium · Delayed Price · Currency is EUR 6.60
+0.10 (1.54%)
At close: Oct 30, 2026
Materialise NV Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 274.18 | 267.63 | 266.77 | 256.13 | 232.02 | 205.45 |
Revenue Growth | 4.19% | 0.33% | 4.15% | 10.39% | 12.93% | 20.54% |
Gross Profit Gross Profit Growth | 157.48 | 152.95 | 150.83 | 145.13 | 128.77 | 118.17 |
Operating Income Operating Income Growth | 9.33 | 8.94 | 9.46 | 15.04 | -3.55 | 12.81 |
Net Income Net Income Growth | 12.73 | 7.72 | 13.44 | 6.72 | -2.12 | 13.15 |
Earnings Per Share EPS Growth | 0.21 | 0.13 | 0.23 | 0.11 | -0.04 | 0.23 |
EPS Growth | 180.86% | -42.85% | 106.79% | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Materialise Medical Materialise Medical Growth | 143.6 | 134.24 | 116.36 | 101.38 | 84.85 | 73.37 |
Materialise Software Materialise Software Growth | 40.08 | 40.91 | 43.9 | 44.44 | 43.69 | 42.9 |
Materialise Manufacturing Materialise Manufacturing Growth | 90.51 | 92.49 | 106.51 | 110.31 | 103.49 | 89.18 |
Total Total Growth | 274.18 | 267.63 | 266.77 | 256.13 | 232.02 | 205.45 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 153.53 | 133.92 | 102.3 | 127.57 | 140.87 | 196.03 |
Total Debt Total Debt Growth | 71.06 | 63.11 | 41.28 | 64.4 | 80.98 | 99.11 |
Net Cash (Debt) Net Cash Growth | 82.47 | 70.81 | 61.02 | 63.18 | 59.89 | 96.92 |
Net Cash Growth | 21.74% | 16.04% | -3.41% | 5.49% | -38.21% | - |
Net Cash Per Share Net Cash Per Share Growth | 1.41 | 1.20 | 1.03 | 1.07 | 1.01 | 1.71 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 30 | 25.32 | 31.46 | 20.16 | 22.29 | 25.85 |
Capital Expenditures CapEx Growth | -8.07 | -14.09 | -24.65 | -9.24 | -21.61 | -7.93 |
Free Cash Flow Free Cash Flow Growth | 21.93 | 11.23 | 6.81 | 10.92 | 0.68 | 17.91 |
Free Cash Flow Growth | 156.60% | 64.93% | -37.68% | 1506.18% | -96.20% | -5.46% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 57.44% | 57.15% | 56.54% | 56.66% | 55.50% | 57.52% |
Operating Margin | 3.40% | 3.34% | 3.54% | 5.87% | -1.53% | 6.23% |
Pretax Margin | 4.57% | 2.72% | 5.30% | 2.64% | -0.51% | 6.69% |
Profit Margin | 4.64% | 2.88% | 5.04% | 2.62% | -0.92% | 6.40% |
FCF Margin | 8.00% | 4.20% | 2.55% | 4.26% | 0.29% | 8.72% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 31.35 | 36.18 | 29.89 | 52.19 | - | 93.78 |
P/FCF Ratio | 16.97 | 24.87 | 59.01 | 32.12 | 715.20 | 68.87 |
PS Ratio | 1.36 | 1.04 | 1.51 | 1.37 | 2.10 | 6.00 |